The clinical outcomes are complex and often involve multiple systemic burdens. Early identification and standardized clinical care are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical outcomes, imaging inspections, laboratory tests and pathological evaluations.
The platform can assist in matching a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment and management of Behçet's disease requires individualized management, which typically includes drug therapy, rehabilitation, regular follow-up, and other multidimensional management. In recent years, with the development of treatment-oriented, immune-regulatory treatments and precision medicine, many autoimmune and rheumatic immune diseases that were previously difficult to treat have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely schemes according to changes in conditions. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of Behçet's meningitis. The platform serves a team of internationally authoritative experts in the field of self-immunity and rheumatic immunity in China.
2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4.
Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.